id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2003-N-0163-0001,FDA,FDA-2003-N-0163,FDA,Notice,NWL-Notice of Withdrawl,2005-12-29T05:00:00Z,2005,12,2005-12-27T05:00:00Z,,2008-04-12T00:59:12Z,,0,0,09000064804886b0
FDA-2005-P-0123-0001,FDA,FDA-2005-P-0123,"Determination That DECADRON (Dexam@thasone) Tablets, 1.5 Milligrams,
Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,N-Notice,2005-12-29T05:00:00Z,2005,12,2005-12-27T05:00:00Z,,2024-12-13T19:52:31Z,,0,0,090000648043fc0c
FDA-2005-N-0467-0001,FDA,FDA-2005-N-0467,Animal Drug User Fee Act; Public Meeting,Notice,Meeting,2005-12-29T05:00:00Z,2005,12,2005-12-27T05:00:00Z,2006-03-27T04:59:59Z,2025-10-17T19:51:43Z,E5-7876,0,0,0900006480450dda
FDA-2005-N-0044-0002,FDA,FDA-2005-N-0044,"Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Device Reporting: Manufacturer Reporting, Importer Reporting, User Facility Reporting, and Distributor Reporting",Notice,60 Day Proposed Information Collection,2005-12-29T05:00:00Z,2005,12,2005-12-23T05:00:00Z,2006-02-03T04:59:59Z,2025-10-17T19:03:49Z,E5-7726,0,0,090000648043eafe
FDA-2004-P-0336-0004,FDA,FDA-2004-P-0336,FDA,Notice,NIR-Notice of Interim Rule,2005-12-29T05:00:00Z,2005,12,2005-12-23T05:00:00Z,2006-03-09T04:59:59Z,2008-04-12T00:49:18Z,,0,0,09000064804732ca
FDA-2005-D-0084-0004,FDA,FDA-2005-D-0084,FDA,Notice,NAD-Notice of Availability of Data,2005-12-27T05:00:00Z,2005,12,2005-12-22T05:00:00Z,2006-03-14T04:59:59Z,2008-04-11T23:46:31Z,,0,0,090000648043f444
FDA-2005-D-0084-0001,FDA,FDA-2005-D-0084,FDA,Notice,NAD-Notice of Availability of Data,2005-12-27T05:00:00Z,2005,12,2005-12-22T05:00:00Z,2006-03-14T04:59:59Z,2008-04-11T23:46:31Z,,0,0,090000648043f435
FDA-2005-D-0227-0001,FDA,FDA-2005-D-0227,"Questions and Answers Regarding Food Allergens, including the Food Allergen Labeling and Consumer Protection Act of 2004; Availability (Edition 2)",Notice,NAD-Notice of Availability of Data,2005-12-27T05:00:00Z,2005,12,2005-12-23T05:00:00Z,2006-12-28T04:59:59Z,2008-07-09T14:52:06Z,,0,0,090000648044205e
FDA-2005-N-0469-0001,FDA,FDA-2005-N-0469,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Reclassification Petitions for Medical Devices,Notice,30 Day Proposed Information Collection,2005-12-27T05:00:00Z,2005,12,2005-12-23T05:00:00Z,,2025-10-08T01:51:00Z,E5-7804,0,0,0900006480450e3e
FDA-2005-N-0096-0001,FDA,FDA-2005-N-0096,"Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of New Animal Drug Applications",Notice,Withdrawal,2005-12-23T05:00:00Z,2005,12,2005-12-15T05:00:00Z,,2025-06-19T01:11:14Z,,0,0,090000648043f7c3
FDA-2003-N-0154-0004,FDA,FDA-2003-N-0154,"Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Research Study
Complaint Form",Notice,30 Day Proposed Information Collection,2005-12-23T05:00:00Z,2005,12,2005-12-16T05:00:00Z,2006-01-18T04:59:59Z,2025-03-12T13:12:59Z,05-24102,0,0,090000648048760b
FDA-2004-P-0223-0005,FDA,FDA-2004-P-0223,FDA - Notice of Meeting,Notice,NM-Notice of Meeting,2005-12-22T05:00:00Z,2005,12,2005-12-21T05:00:00Z,2006-03-11T04:59:59Z,2009-04-21T19:53:09Z,,0,0,0900006480471211
FDA-2005-D-0335-0008,FDA,FDA-2005-D-0335,FDA,Notice,N-Notice,2005-12-22T05:00:00Z,2005,12,2005-12-21T05:00:00Z,2006-01-24T04:59:59Z,2008-04-11T23:47:17Z,,0,0,0900006480448cf9
FDA-2005-N-0240-0002,FDA,FDA-2005-N-0240,Agency Information Collection Activities; Proposed Collection; Comment Request; FDA Public Health Notification (formerly known as Safety Alert/Public Health Advisory) Readership Survey,Notice,60 Day Proposed Information Collection,2005-12-22T05:00:00Z,2005,12,2005-12-21T05:00:00Z,2006-02-22T04:59:59Z,2025-10-17T19:36:13Z,E5-7642,0,0,09000064804440ae
FDA-2005-N-0291-0001,FDA,FDA-2005-N-0291,Regulatory Process for Pediatric Mechanical Circulatory Support Devices (Ventricular Assist Devices),Notice,Meeting,2005-12-21T05:00:00Z,2005,12,2005-12-19T05:00:00Z,,2025-10-17T19:21:08Z,05-24271,0,0,0900006480445d51
FDA-1980-N-0049-0163,FDA,FDA-1980-N-0049,Biological Products; Bacterial Vaccines and Toxoids; Implementation of Efficacy Review,Notice,Notice of Final Rule,2005-12-21T05:00:00Z,2005,12,2005-12-15T05:00:00Z,,2020-09-25T13:40:57Z,05-24224,0,0,09000064805ba0aa
FDA-1980-N-0049-0162,FDA,FDA-1980-N-0049,Biological Products; Bacterial Vaccines and Toxoids; Implementation of Efficacy Review; Anthrax Vaccine Adsorbed; Final Order,Notice,General Notice,2005-12-21T05:00:00Z,2005,12,2005-12-15T05:00:00Z,,2020-09-25T13:43:01Z,05-24223,0,0,09000064805ba0a9
FDA-2005-D-0287-0001,FDA,FDA-2005-D-0287,FDA,Notice,NAD-Notice of Availability of Data,2005-12-15T05:00:00Z,2005,12,2005-12-13T05:00:00Z,,2008-04-11T23:47:13Z,,0,0,09000064804458bf
FDA-2004-N-0052-0005,FDA,FDA-2004-N-0052,Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Food and Drug Administration Recall Regulations (Guidelines),Notice,Notice of Approval,2005-12-15T05:00:00Z,2005,12,,,2025-09-26T22:19:26Z,05-24042,0,0,090000648046e8d8
FDA-2005-N-0470-0002,FDA,FDA-2005-N-0470,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Reprocessed Single-Use Device Labeling,Notice,30 Day Proposed Information Collection,2005-12-15T05:00:00Z,2005,12,,,2025-10-08T19:51:34Z,05-24041,0,0,0900006480450e57
FDA-2005-N-0230-0004,FDA,FDA-2005-N-0230,Agency Information Collection Activities; Proposed Collection; Comment Request; Evaluation of Consumer-Friendly Formats for Brief Summary in Direct-to-Consumer Print Advertisements for Prescription Drugs: Study 1,Notice,30 Day Proposed Information Collection,2005-12-15T05:00:00Z,2005,12,,,2025-09-16T20:45:50Z,05-24040,0,0,090000648044216d
FDA-2005-N-0332-0001,FDA,FDA-2005-N-0332,FDA,Notice,NPR-Notice of Proposed Rule-Making,2005-12-13T05:00:00Z,2005,12,2005-12-08T05:00:00Z,2006-03-10T04:59:59Z,2008-04-11T23:54:09Z,,0,0,0900006480448990
FDA-2005-N-0093-0001,FDA,FDA-2005-N-0093,FDA,Notice,N-Notice,2005-12-13T05:00:00Z,2005,12,2005-12-12T05:00:00Z,2006-01-13T04:59:59Z,2008-04-11T23:49:48Z,,0,0,090000648043f569
FDA-2005-C-0359-0001,FDA,FDA-2005-C-0359,"Food Ingredient Solutions, LLC; Filing of Color Additive Petition",Notice,Notice of Filing,2005-12-13T05:00:00Z,2005,12,,,2025-12-04T17:53:51Z,05-23812,0,0,090000648044a7fa
FDA-2005-D-0399-0001,FDA,FDA-2005-D-0399,FDA,Notice,NAD-Notice of Availability of Data,2005-12-08T05:00:00Z,2005,12,2005-12-07T05:00:00Z,2006-03-09T04:59:59Z,2008-04-11T23:47:32Z,,0,0,090000648044cfee
FDA-2005-N-0297-0001,FDA,FDA-2005-N-0297,Agency Information Collection Activities; Proposed Collection; Comment Request; Notice of a Claim for Generally Recognized as Safe Exemption Based on a Generally Recognized as Safe Determination,Notice,60 Day Proposed Information Collection,2005-12-08T05:00:00Z,2005,12,2005-12-07T05:00:00Z,2006-02-07T04:59:59Z,2025-10-17T09:00:19Z,05-23747,0,0,0900006480446d95
FDA-2005-N-0228-0005,FDA,FDA-2005-N-0228,Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; State Enforcement Notifications,Notice,Notice of Approval,2005-12-08T05:00:00Z,2005,12,2005-12-07T05:00:00Z,,2025-10-04T01:37:49Z,05-23744,0,0,09000064804420cc
FDA-2004-N-0054-0008,FDA,FDA-2004-N-0054,Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; MedWatch: Food and Drug Administration Medical Products Reporting Program,Notice,Notice of Approval,2005-12-08T00:00:00Z,2005,12,,,2025-05-12T22:33:18Z,70 FR 72843,0,0,090000648046e913
FDA-2005-N-0232-0001,FDA,FDA-2005-N-0232,Revocation of Status of Specific Products; Group A Streptococcus; Companion Document to Direct Final Rule,Notice,General Notice,2005-12-07T05:00:00Z,2005,12,2005-12-02T05:00:00Z,2006-02-16T04:59:59Z,2025-10-08T19:09:26Z,05-23545,0,0,09000064804421bb
FDA-2005-N-0232-0008,FDA,FDA-2005-N-0232,Revocation of Status of Specific Products; Group A Streptococcus,Notice,Notice of Final Rule,2005-12-07T05:00:00Z,2005,12,2005-12-02T05:00:00Z,2006-02-16T04:59:59Z,2025-10-08T19:14:21Z,05-23546,0,0,090000648044224a
FDA-2005-N-0454-0001,FDA,FDA-2005-N-0454,FDA,Notice,"NRD-Notice of Requesting Data, Info, & Views",2005-12-05T05:00:00Z,2005,12,2005-12-05T05:00:00Z,2006-03-07T04:59:59Z,2009-12-30T22:03:14Z,,0,0,09000064804507fc
FDA-2005-N-0021-0001,FDA,FDA-2005-N-0021,Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Dandruff Control Ingredient,Notice,"NRD-Notice of Requesting Data, Info, & Views",2005-12-05T05:00:00Z,2005,12,2005-12-05T05:00:00Z,2006-03-07T04:59:59Z,2020-10-29T12:03:48Z,,0,0,090000648043e759
FDA-2004-G-0002-0004,FDA,FDA-2004-G-0002,"Guidance for Industry and Food and Drug Administration Staff, Guidance for Records Access Authority Provided In Title III, Subtitle A, of the Public Health Security and Bioterrorism Preparedness and Response Act of 2002; Availability",Notice,Notice of Data Availability,2005-12-02T05:00:00Z,2005,12,2005-11-30T05:00:00Z,,2025-11-13T20:43:47Z,05-23504,0,0,090000648046a75b
FDA-2005-N-0041-0002,FDA,FDA-2005-N-0041,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Medical Device Recall Authority,Notice,30 Day Proposed Information Collection,2005-12-02T05:00:00Z,2005,12,,,2025-10-07T20:49:34Z,05-23519,0,0,090000648043eae1
FDA-2005-D-0208-0001,FDA,FDA-2005-D-0208,"Guidance for Industry: Safety, Efficacy, and Pharmacokinetic Studies to Support Marketing of Immune Globulin Intravenous (Human) as Replacement Therapy for Primary Humoral Immunodeficiency; Availability",Notice,NAD-Notice of Availability of Data,2005-12-02T05:00:00Z,2005,12,2005-11-30T05:00:00Z,2006-03-02T04:59:59Z,2008-07-18T05:09:10Z,,0,0,0900006480441234
FDA-2005-N-0453-0001,FDA,FDA-2005-N-0453,Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredients,Notice,"NRD-Notice of Requesting Data, Info, & Views",2005-12-02T05:00:00Z,2005,12,2005-12-05T05:00:00Z,2006-03-07T04:59:59Z,2009-12-30T19:54:55Z,,0,0,09000064804507c9
FDA-2004-P-0008-0002,FDA,FDA-2004-P-0008,FDA,Notice,NPR-Notice of Proposed Rule-Making,2005-12-01T05:00:00Z,2005,12,2005-11-25T05:00:00Z,2006-02-03T04:59:59Z,2008-04-12T00:46:48Z,,0,0,090000648046a7f7
FDA-2005-N-0169-0001,FDA,FDA-2005-N-0169,FDA,Notice,NM-Notice of Meeting,2005-12-01T05:00:00Z,2005,12,2005-11-28T05:00:00Z,2006-01-25T04:59:59Z,2008-04-11T23:50:59Z,,0,0,0900006480440bc0
FDA-2005-N-0304-0001,FDA,FDA-2005-N-0304,Agency Information Collection Activities; Proposed Collection; Comment Request; Focus Groups as Used by the Food and Drug Administration,Notice,60 Day Proposed Information Collection,2005-12-01T05:00:00Z,2005,12,2005-11-25T05:00:00Z,2006-01-25T04:59:59Z,2025-10-16T22:19:30Z,05-23248,0,0,090000648044723a
FDA-2005-P-0259-0003,FDA,FDA-2005-P-0259,Request for Comment on the Status of Pyridoxamine,Notice,Notice of Action Taken,2005-11-22T05:00:00Z,2005,11,2005-11-18T05:00:00Z,2005-12-20T04:59:59Z,2025-03-29T18:56:22Z,,0,0,09000064804444e1
FDA-2005-N-0030-0006,FDA,FDA-2005-N-0030,Agency Information Collection Activities: Announcement of Office of Management and Budget Approval; Regulations For In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring,Notice,Notice of Approval,2005-11-22T05:00:00Z,2005,11,2005-11-22T05:00:00Z,,2025-10-24T00:40:54Z,05-23039,0,0,090000648043e880
FDA-2005-N-0168-0004,FDA,FDA-2005-N-0168,"Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Requesting an Extension to Use Existing Label Stock After the Trans Fat Labeling Effective Date of January 1, 2006",Notice,Notice of Approval,2005-11-22T05:00:00Z,2005,11,2005-11-21T05:00:00Z,,2025-10-08T00:01:52Z,05-23040,0,0,0900006480440baf
FDA-2005-D-0226-0004,FDA,FDA-2005-D-0226,FDA,Notice,NAD-Notice of Availability of Data,2005-11-22T05:00:00Z,2005,11,2005-11-21T05:00:00Z,,2008-04-11T23:47:01Z,,0,0,0900006480441ff3
FDA-2005-N-0168-0005,FDA,FDA-2005-N-0168,"Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Requesting an Extension to Use Existing Label Stock After the Trans Fat Labeling Effective Date of January 1, 2006",Notice,60 Day Proposed Information Collection,2005-11-22T05:00:00Z,2005,11,2005-11-21T05:00:00Z,,2025-10-08T00:04:53Z,05-23041,0,0,0900006480440bb0
FDA-1998-D-0085-0005,FDA,FDA-1998-D-0085,FDA,Notice,NAD-Notice of Availability of Data,2005-11-18T05:00:00Z,2005,11,2005-11-15T05:00:00Z,2006-01-18T04:59:59Z,2008-05-16T21:23:13Z,,0,0,0900006480584fcf
FDA-2004-F-0136-0002,FDA,FDA-2004-F-0136,Food Additives Permitted for Direct Addition to Food for Human Consumption; Vitamin D3,Notice,Notice of Final Rule,2005-11-18T05:00:00Z,2005,11,2005-11-16T05:00:00Z,2005-12-17T04:59:59Z,2025-11-13T02:05:16Z,05-22670,0,0,090000648046fdcc
FDA-2005-N-0039-0001,FDA,FDA-2005-N-0039,Agency Information Collection Activities; Proposed Collection; Comment Request; Filing Objections and Requests for a Hearing on a Regulation or Order,Notice,60 Day Proposed Information Collection,2005-11-18T05:00:00Z,2005,11,2005-11-15T05:00:00Z,2006-01-18T04:59:59Z,2025-10-11T01:58:14Z,05-22753,0,0,090000648043ea8c
FDA-2005-N-0031-0003,FDA,FDA-2005-N-0031,Agency Information Collection Activities: Submission for Office of Management and Budget Review; Comment Request; Importer's Entry Notice,Notice,30 Day Proposed Information Collection,2005-11-18T05:00:00Z,2005,11,,,2025-10-07T02:14:18Z,05-22671,0,0,090000648043e891
FDA-2005-N-0296-0001,FDA,FDA-2005-N-0296,Agency Information Collection Activities; Proposed Collection; Comment Request; General Administrative Procedures: Citizen Petitions; Petition for Reconsideration or Stay of Action; Advisory Opinions,Notice,60 Day Proposed Information Collection,2005-11-18T05:00:00Z,2005,11,2005-11-15T05:00:00Z,2006-01-18T04:59:59Z,2025-10-11T01:16:43Z,05-22668,0,0,0900006480446cef
FDA-2005-N-0032-0002,FDA,FDA-2005-N-0032,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Record Retention Requirements for the Soy Protein and Risk of Coronary Heart Disease Health Claim,Notice,30 Day Proposed Information Collection,2005-11-15T05:00:00Z,2005,11,2005-11-14T05:00:00Z,,2025-10-07T20:28:59Z,05-22636,0,0,090000648043e8af
FDA-2005-N-0471-0002,FDA,FDA-2005-N-0471,Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Survey on Program Funding,Notice,Notice of Approval,2005-11-15T05:00:00Z,2005,11,2005-11-14T05:00:00Z,,2025-10-24T01:41:59Z,05-22637,0,0,0900006480450e6c
FDA-2004-N-0319-0002,FDA,FDA-2004-N-0319,Environmental Assessment; Categorical Exclusions,Notice,Notice of Final Rule,2005-11-15T00:00:00Z,2005,11,,,2025-05-06T16:56:28Z,05-22563,0,0,0900006480473028
FDA-2003-D-0435-0022,FDA,FDA-2003-D-0435,Revised Compliance Policy Guide Regarding Prior Notice of Imported Food Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002; Availability,Notice,NAD-Notice of Availability of Data,2005-11-14T05:00:00Z,2005,11,2005-11-14T05:00:00Z,2006-11-15T04:59:59Z,2009-05-13T22:23:05Z,,0,0,09000064804a2379
FDA-2004-D-0375-0001,FDA,FDA-2004-D-0375,FDA,Notice,NAD-Notice of Availability of Data,2005-11-14T05:00:00Z,2005,11,2005-11-14T05:00:00Z,2006-02-14T04:59:59Z,2008-11-07T13:05:35Z,,0,0,0900006480473751
FDA-2005-P-0374-0001,FDA,FDA-2005-P-0374,Medical Devices; General and Plastic Surgery Devices; Classification of the Low Energy Ultrasound Wound Cleaner,Notice,Notice of Final Rule,2005-11-10T05:00:00Z,2005,11,2005-11-04T05:00:00Z,,2025-03-20T14:23:21Z,,0,0,090000648044b811
FDA-2003-N-0319-0004,FDA,FDA-2003-N-0319,"Agency Information Collection, Activities; Submission for Office of Management and Budget Review; Comment Request; Study to Measure the Compliance of Prescribers With the Contraindication of the Use of Triptans in Migraine Headache Patients With Vascular Disease",Notice,30 Day Proposed Information Collection,2005-11-10T05:00:00Z,2005,11,2005-11-02T05:00:00Z,2005-12-03T04:59:59Z,2025-06-17T17:03:30Z,05-21807,0,0,09000064804956b9
FDA-2001-D-0573-0007,FDA,FDA-2001-D-0573,FDA,Notice,NAD-Notice of Availability of Data,2005-11-10T05:00:00Z,2005,11,2005-11-09T05:00:00Z,2006-11-10T04:59:59Z,2008-04-25T02:39:21Z,,0,0,090000648050b1d0
FDA-2005-D-0085-0001,FDA,FDA-2005-D-0085,FDA,Notice,NAD-Notice of Availability of Data,2005-11-09T05:00:00Z,2005,11,2005-11-07T05:00:00Z,2006-02-07T04:59:59Z,2008-04-11T23:46:33Z,,0,0,090000648043f47e
FDA-2005-N-0298-0001,FDA,FDA-2005-N-0298,FDA,Notice,NPR-Notice of Proposed Rule-Making,2005-11-08T05:00:00Z,2005,11,2005-11-07T05:00:00Z,2006-02-07T04:59:59Z,2008-04-11T23:54:03Z,,0,0,0900006480446e24
FDA-2004-D-0370-0007,FDA,FDA-2004-D-0370,FDA,Notice,NAD-Notice of Availability of Data,2005-11-08T05:00:00Z,2005,11,2005-11-07T05:00:00Z,2006-11-09T04:59:59Z,2008-04-12T00:35:56Z,,0,0,09000064804736e4
FDA-2004-N-0451-0005,FDA,FDA-2004-N-0451,"Food and Drug Administration Modernization Act of 1997: Modifications to the List of Recognized Standards, Recognition List Number: 013",Notice,Notice of Publication,2005-11-08T05:00:00Z,2005,11,2005-11-08T05:00:00Z,,2025-04-16T15:43:15Z,05-22267,0,0,090000648047542b
FDA-2005-N-0233-0001,FDA,FDA-2005-N-0233,Change of Name; Technical Amendment,Notice,N-Notice,2005-11-08T05:00:00Z,2005,11,2005-11-07T05:00:00Z,,2025-10-09T22:55:49Z,05-22167,0,0,0900006480442262
FDA-2005-N-0095-0001,FDA,FDA-2005-N-0095,FDA,Notice,NM-Notice of Meeting,2005-11-07T05:00:00Z,2005,11,2005-11-04T05:00:00Z,,2008-04-11T23:49:59Z,,0,0,090000648043f79f
FDA-2005-N-0099-0002,FDA,FDA-2005-N-0099,FDA,Notice,NCR-Notice of Correction,2005-11-07T05:00:00Z,2005,11,2005-10-27T04:00:00Z,,2008-04-11T23:50:04Z,,0,0,090000648043f81b
FDA-2002-E-0283-0004,FDA,FDA-2002-E-0283,Determination of Regulatory Review Period for Purposes of Patent Extension; ZOMETA; Correction,Notice,Correction,2005-11-07T05:00:00Z,2005,11,,,2025-09-30T18:16:40Z,05-22012,0,0,090000648049eaa1
FDA-2005-G-0193-0001,FDA,FDA-2005-G-0193,"Guidance for Industry and Food and Drug Administration Staff; Class II Special Controls Guidance Document: Low Energy Ultrasound Wound
Cleaner; Availability",Notice,Notice of Data Availability,2005-11-07T05:00:00Z,2005,11,2005-11-07T05:00:00Z,,2025-12-04T01:23:48Z,05–22069,0,0,0900006480440e70
FDA-2005-N-0239-0001,FDA,FDA-2005-N-0239,Agency Information Collection Activities; Proposed Collection; Comment Request; Emergency Shortages Data Collection System (Formerly the Emergency Medical Device Shortage Program Survey),Notice,60 Day Proposed Information Collection,2005-11-07T05:00:00Z,2005,11,2005-11-04T05:00:00Z,2006-01-04T04:59:59Z,2025-07-15T17:47:47Z,,0,0,090000648044409e
FDA-2004-N-0186-0004,FDA,FDA-2004-N-0186,Agency information Collection Activities; Announcement of Office of Management and Budget Approval; 2005 Food Safety Survey; Correction,Notice,Correction,2005-11-07T00:00:00Z,2005,11,,,2025-05-09T00:04:56Z,05-21974,0,0,0900006480470292
FDA-2005-N-0348-0001,FDA,FDA-2005-N-0348,Agency Information Collection Activities; Proposed Collection; Comment Request; Notice of Participation,Notice,60 Day Proposed Information Collection,2005-11-01T05:00:00Z,2005,11,2005-10-31T04:00:00Z,2006-01-04T04:59:59Z,2025-10-11T01:43:23Z,05-21774,0,0,0900006480449e6d
FDA-2005-D-0337-0001,FDA,FDA-2005-D-0337,FDA,Notice,NAD-Notice of Availability of Data,2005-11-01T05:00:00Z,2005,11,2005-11-01T05:00:00Z,2006-11-02T04:59:59Z,2008-04-11T23:47:19Z,,0,0,0900006480448edc
FDA-2005-D-0456-0001,FDA,FDA-2005-D-0456,FDA,Notice,NAD-Notice of Availability of Data,2005-10-27T04:00:00Z,2005,10,2005-10-25T04:00:00Z,,2008-04-11T23:47:40Z,,0,0,0900006480450906
FDA-2005-P-0001-0001,FDA,FDA-2005-P-0001,Medical Devices; Immunology and Microbiology Devices; Classification of Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutation Detection System,Notice,Notice of Final Rule,2005-10-27T04:00:00Z,2005,10,2005-10-25T04:00:00Z,,2025-03-20T14:27:26Z,,0,0,090000648043af8b
FDA-2005-N-0351-0002,FDA,FDA-2005-N-0351,Agency Information Collection Activities; Proposed Collection; Comment Request; Generic Food and Drug Administration Rapid Response Surveys,Notice,60 Day Proposed Information Collection,2005-10-27T04:00:00Z,2005,10,2005-10-24T04:00:00Z,2005-12-28T04:59:59Z,2025-10-24T01:37:11Z,05-21240,0,0,090000648044a08f
FDA-2005-N-0160-0002,FDA,FDA-2005-N-0160,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Food Contact Substances Notification,Notice,30 Day Proposed Information Collection,2005-10-25T04:00:00Z,2005,10,2005-10-21T04:00:00Z,,2025-10-06T21:55:56Z,05-21155,0,0,09000064804403cb
FDA-2005-N-0288-0002,FDA,FDA-2005-N-0288,Agency Information Collection Activities; Submission Management and Budget Review; Comment Request; Medical Devices: Humanitarian Use Devices,Notice,30 Day Proposed Information Collection,2005-10-25T04:00:00Z,2005,10,2005-10-21T04:00:00Z,,2025-10-06T22:14:12Z,05-21158,0,0,0900006480445a35
FDA-2005-N-0299-0001,FDA,FDA-2005-N-0299,Agency Information Collection Activities: Proposed Collection; Comment Request; Guidance for Industry on Formal Meetings with Sponsors and Applicants for Prescription Drug User Fee Act Products,Notice,60 Day Proposed Information Collection,2005-10-25T04:00:00Z,2005,10,2005-10-24T04:00:00Z,2005-12-24T04:59:59Z,2025-10-08T22:28:41Z,05-21151,0,0,0900006480446ec0
FDA-2004-D-0045-0005,FDA,FDA-2004-D-0045,FDA,Notice,30 Day Proposed Information Collection,2005-10-25T04:00:00Z,2005,10,2005-10-21T04:00:00Z,,2016-08-05T13:58:14Z,,0,0,090000648046e856
FDA-2005-N-0161-0002,FDA,FDA-2005-N-0161,FDA,Notice,N-Notice,2005-10-25T04:00:00Z,2005,10,2005-10-21T04:00:00Z,,2008-04-11T23:50:21Z,,0,0,09000064804403fc
FDA-2005-N-0106-0001,FDA,FDA-2005-N-0106,Agency Information Collection Activities: Proposed Collection; Comment Request; Guidance for Industry on Formal Dispute Resolution; Appeals Above the Division Level,Notice,60 Day Proposed Information Collection,2005-10-25T04:00:00Z,2005,10,2005-10-24T04:00:00Z,,2025-10-08T22:44:15Z,05-21156,0,0,090000648043f948
FDA-2004-N-0186-0003,FDA,FDA-2004-N-0186,Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; 2005 Food Safety Survey,Notice,Notice of Approval,2005-10-25T00:00:00Z,2005,10,,,2025-05-08T23:58:48Z,05-21157,0,0,0900006480470290
FDA-2004-D-0366-0006,FDA,FDA-2004-D-0366,FDA,Notice,NAD-Notice of Availability of Data,2005-10-20T04:00:00Z,2005,10,2005-10-19T04:00:00Z,,2008-04-12T00:35:52Z,,0,0,09000064804736ab
FDA-2005-D-0014-0001,FDA,FDA-2005-D-0014,FDA,Notice,NAD-Notice of Availability of Data,2005-10-20T04:00:00Z,2005,10,2005-10-19T04:00:00Z,2006-01-19T04:59:59Z,2008-04-11T23:46:17Z,,0,0,090000648043e54f
FDA-2004-D-0241-0006,FDA,FDA-2004-D-0241,FDA,Notice,NAD-Notice of Availability of Data,2005-10-20T04:00:00Z,2005,10,2005-10-19T04:00:00Z,,2008-04-12T00:35:20Z,,0,0,0900006480471999
FDA-2000-P-0152-0002,FDA,FDA-2000-P-0152,FDA,Notice,NPR-Notice of Proposed Rule-Making,2005-10-19T04:00:00Z,2005,10,2005-10-18T04:00:00Z,2020-03-31T03:59:59Z,2020-01-14T02:04:19Z,,0,0,09000064804d1295
FDA-2005-N-0295-0001,FDA,FDA-2005-N-0295,Assessing Consumer Perceptions of Health Claims; Public Meeting; Request for Comments,Notice,NM-Notice of Meeting,2005-10-19T04:00:00Z,2005,10,2005-10-17T04:00:00Z,2006-01-18T04:59:59Z,2010-03-19T20:56:27Z,,0,0,0900006480446aac
FDA-2003-D-0197-0001,FDA,FDA-2003-D-0197,FDA,Notice,NAD-Notice of Availability of Data,2005-10-19T04:00:00Z,2005,10,2005-10-18T04:00:00Z,,2008-04-12T00:54:53Z,,0,0,090000648048b78f
FDA-2005-N-0099-0001,FDA,FDA-2005-N-0099,FDA,Notice,NM-Notice of Meeting,2005-10-18T04:00:00Z,2005,10,2005-10-14T04:00:00Z,2005-12-15T04:59:59Z,2008-04-11T23:50:03Z,,0,0,090000648043f811
FDA-2005-N-0107-0002,FDA,FDA-2005-N-0107,Pediatric Ethics Subcommittee of the Pediatric Advisory Committee; Notice of Meeting,Notice,Meeting,2005-10-14T04:00:00Z,2005,10,2005-10-06T04:00:00Z,,2025-10-09T21:32:48Z,05-20302,0,0,090000648043f96a
FDA-2005-N-0107-0001,FDA,FDA-2005-N-0107,Solicitation of Public Review and Comment on Research Protocol: Gonadotropin-releasing Hormone Agonist Test in Disorders of Puberty,Notice,Request for Comments,2005-10-14T04:00:00Z,2005,10,2005-10-07T04:00:00Z,2005-11-02T04:59:59Z,2025-10-10T09:00:11Z,05-20301,0,0,090000648043f968
FDA-2005-N-0466-0002,FDA,FDA-2005-N-0466,Agency information Collection Activities; Submission for Office of Management and Budget Review; Regulations Under the Federal Import Milk Act,Notice,30 Day Proposed Information Collection,2005-10-14T04:00:00Z,2005,10,,,2025-10-24T00:52:00Z,05-20148,0,0,0900006480450dc9
FDA-2005-N-0406-0001,FDA,FDA-2005-N-0406,Agency Information Collection Activities: Proposed Collection; Comment Request; Investigational New Drug Regulations,Notice,60 Day Proposed Information Collection,2005-10-12T04:00:00Z,2005,10,2005-10-11T04:00:00Z,2005-12-13T04:59:59Z,2025-07-11T22:24:42Z,,0,0,090000648044edc2
FDA-2005-N-0290-0004,FDA,FDA-2005-N-0290,"Agency lnformation Collection Activities; Announcement of Office of Management and Budget Approval; General Licensing Provisions: Biologics License Application, Changes to an Approved Application, Labeling, Revocation and Suspension, and Forms FDA 356h and 2567",Notice,Notice of Approval,2005-10-11T04:00:00Z,2005,10,2005-10-10T04:00:00Z,,2025-10-23T22:46:13Z,05-20306,0,0,0900006480445c6a
FDA-2005-N-0229-0006,FDA,FDA-2005-N-0229,Agency Information Collection Activities; Announcement of Management and Budget Approval; Guidance for industry: Notification of a Health Claim or Nutrient Content Claim Based on an Authoritative Statement of a Scientific Body,Notice,Notice of Approval,2005-10-11T04:00:00Z,2005,10,2005-10-10T04:00:00Z,,2025-10-24T00:29:50Z,05-20308,0,0,0900006480442159
FDA-2004-N-0126-0004,FDA,FDA-2004-N-0126,"Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Industry: Fast Track Drug
Development Programs-Designation, Development, and Application Review",Notice,Notice of Approval,2005-10-11T04:00:00Z,2005,10,,,2025-06-05T18:56:42Z,05-20305,0,0,090000648046fcbb
FDA-2005-D-0156-0001,FDA,FDA-2005-D-0156,FDA,Notice,NAD-Notice of Availability of Data,2005-10-11T04:00:00Z,2005,10,2005-10-10T04:00:00Z,2005-10-12T03:59:59Z,2008-04-11T23:46:46Z,,0,0,0900006480440268
FDA-2004-N-0450-0007,FDA,FDA-2004-N-0450,"Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter Human Use; Amendment of Final Monograph for Over-the-Counter Nasal Decongestant Druq Products",Notice,Notice of Final Rule,2005-10-11T04:00:00Z,2005,10,2005-10-10T04:00:00Z,,2025-09-26T17:39:57Z,05-20304,0,0,0900006480475408
FDA-2005-N-0090-0002,FDA,FDA-2005-N-0090,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Cosmetic Product Voluntary Reporting Program,Notice,30 Day Proposed Information Collection,2005-10-11T04:00:00Z,2005,10,,,2025-10-06T22:21:42Z,05-20307,0,0,090000648043f51a
FDA-2005-D-0458-0001,FDA,FDA-2005-D-0458,FDA,Notice,NAD-Notice of Availability of Data,2005-10-06T04:00:00Z,2005,10,2005-10-05T04:00:00Z,2006-01-05T04:59:59Z,2008-04-11T23:47:43Z,,0,0,0900006480450967
FDA-2002-N-0323-0163,FDA,FDA-2002-N-0323,Registration of Food Facilities Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002; Final Rule,Notice,NFR-Notice of Final Rule,2005-10-05T04:00:00Z,2005,10,2005-09-30T04:00:00Z,,2009-10-27T19:51:30Z,,0,0,09000064804a0b54
FDA-2005-D-0088-0001,FDA,FDA-2005-D-0088,FDA,Notice,NAD-Notice of Availability of Data,2005-10-05T04:00:00Z,2005,10,2005-10-03T04:00:00Z,2006-10-04T03:59:59Z,2008-04-11T23:46:35Z,,0,0,090000648043f4a5